How to Buy Legend Biotech Stock
Legend Biotech Corp
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally.
Legend Biotech stock last closed at $44.42, down 1.66% from the previous day, and has decreased 35.25% in one year. It has underperformed other stocks in the Biotechnology industry by 0.12 percentage points. Legend Biotech stock is currently +0.82% from its 52-week low of $44.06, and -42.55% from its 52-week high of $77.32.
As of Apr 25, 2024, there are 363.82M shares of LEGN outstanding. The market cap of LEGN is $8.08B. In the last 24 hours, 1.85M LEGN shares were traded.
How to Buy Legend Biotech Stock
Wondering how to invest in Legend Biotech stock? Here's how.
- Choose where to buy Legend Biotech stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Legend Biotech stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Choose your method of payment and add your information.
- Analyze Legend Biotech stock: The Legend Biotech ticker symbol is LEGN. Is Legend Biotech stock a good investment? Should you buy shares of LEGN? How do LEGN's underlying business fundamentals look? Do top analysts think Legend Biotech is a good buy? Why has LEGN's stock price moved recently? (Hint: Our stock research website can help you figure out if LEGN is a good stock to buy).
- Place your LEGN trade: Decide if you will purchase LEGN shares at the current market price or use a limit order to buy LEGN shares at a specific price.
- Monitor your LEGN investment: Create a watchlist to monitor your position in Legend Biotech shares.
Step 1: Choose where to buy Legend Biotech stock
You will need a brokerage account in order to access the NASDAQ market and buy LEGN shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Financial Services, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal information so you are able to buy LEGN today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on the best stock buying app, you need to deposit funds:
Watch this video walkthrough for more details depositing money into your brokerage account.
Step 4: Analyze Legend Biotech stock
Once you have figured out the best place to buy Legend Biotech stock, it's important to research their stock prior to investing, so you actually comprehend the risk as well as the upside.
Legend Biotech Numbers
Legend Biotech Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on LEGN's stock page.
Is LEGN stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge LEGN's true value.
Using relative valuations ratios:
- LEGN could be overvalued based on its P/B ratio of 6.46x, relative to Biotechnology industry P/B ratio of 5.8x
You can do more valuation research on LEGN's stock here.
LEGN Financial Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the LEGN balance sheet.
- LEGN has cash burn of 460392000. It has sufficient cash and short-term investments to cover this for at least one year.
- Total LEGN debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the LEGN balance sheet.
- LEGN has $1.31B in cash and short term investments. This is enough to cover its annual cash burn of $460.39M.
Failed Financial Due Diligence Checks:
- LEGN has a relatively high debt to equity ratio of 0.48.
- LEGN profit margin has gone up by 2 percentage points in the past year, but the company is still unprofitable.
Is LEGN stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Equities analysts who give forecasts on LEGN, the consensus analyst rating on LEGN is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest LEGN Analyst Upgrades/Downgrades
Leonid Timashev, a bottom 8% analyst from RBC Capital reiterates LEGN with a buy rating and maintains their LEGN price target from $85.00 to $85.00, on Mar 12, 2024.
Gena Wang, a top 35% analyst from Barclays maintains LEGN with a strong buy rating and raises their LEGN price target from $93.00 to $94.00, on Jan 24, 2024.
You can dig deeper into what analysts are saying on the Legend Biotech stock forecast page.
LEGN Momentum
LEGN Performance Numbers
Last year, LEGN revenue was $285.14M. Over the last 5 year, LEGN's revenue has increased by 42.15% per year. This was faster than the Biotechnology industry average of 28.62%.
You can analyze LEGN's earnings and revenue performance here.
Are LEGN insiders buying or selling the stock?
In the last 12 months, insiders at LEGN have not bought or sold any shares.
Research more about who owns LEGN stock here.
Does LEGN provide a stable income stream?
No, Legend Biotech doesn't provide an income stream by paying out dividends.
LEGN Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your LEGN trade
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open button and eToro will execute your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
Step 6: Monitor your LEGN investment
Now that you own some shares in LEGN, you'll want to keep up with your company.
Make a watchlist to monitor your LEGN stock.
LEGN Feed
How to Buy Stock in Legend Biotech
To reiterate, here are the 6 steps to buy stock in Legend Biotech:
- Choose where to buy Legend Biotech stock
- Sign up for your brokerage account
- Deposit funds into your investment account
- Analyze Legend Biotech stock
- Place your LEGN trade
- Monitor your LEGN investment
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Legend Biotech, add LEGN to your watchlist below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.